Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

BRCA1 Antikörper (N-Term)

Name: BRCA1 Antikörper (N-Term)
SKU: ABIN2477707
Price: 468.08 EUR
Availability: InStock

BRCA1 Reaktivität: Human WB, IF, IHC (p), IP, FACS, IHC (fro) Wirt: Maus Monoclonal MS110 unconjugated

(1 reference)

Produktnummer ABIN2477707

Datenblatt (PDF)

Target Alle BRCA1 Antikörper anzeigen

BRCA1 (Breast Cancer 1 (BRCA1))
Bindungsspezifität
22

21

15

15

12

12

10

8

7

6

5

5

4

4

3

3

3

3

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
N-Term
Reaktivität
190

34

26

3

2

1

1

1
Human
Wirt
158

37

2
Maus
Passende Sekundärantikörper
Klonalität
162

35
Monoklonal
Konjugat
88

16

9

6

5

5

5

5

5

5

3

3

3

3

3

3

3

3

3

3

3

2

2

2

2

2

2

2

1
Dieser BRCA1 Antikörper ist unkonjugiert
Applikation
117

61

42

41

38

35

27

23

22

12

11

10

9

9

3

2

2

2

1

1
Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro))

Produktmerkmale

Purified IgG

Aufreinigung

Purified

Immunogen

Recombinant protein corresponding to the N-Terminal region of human BRCA1

Klon

MS110

Isotyp

IgG1

Top Product

Discover our top product BRCA1 Primärantikörper
anti-Breast Cancer 1 (BRCA1) (AA 19-83) antibody
BRCA1 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Breast Cancer 1 (BRCA1) (pSer1423) antibody
BRCA1 Reaktivität: Human, Ratte, Maus WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Breast Cancer 1 (BRCA1) (AA 229-335) antibody
BRCA1 Reaktivität: Human ELISA, IHC Wirt: Maus Monoclonal 6C6D2 unconjugated

anti-Breast Cancer 1 (BRCA1) (AA 400-699) antibody
BRCA1 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Breast Cancer 1 (BRCA1) (AA 1661-1863) antibody
BRCA1 Reaktivität: Human, Ratte, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated

anti-Breast Cancer 1 (BRCA1) (Ser184), (Ser186) antibody
BRCA1 Reaktivität: Human, Ratte WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Breast Cancer 1 (BRCA1) (AA 445-620) antibody
BRCA1 Reaktivität: Human IHC, ISt, StM Wirt: Maus Monoclonal BRCA1-1398 unconjugated

anti-Breast Cancer 1 (BRCA1) (AA 1314-1600), (AA 1314-1864) antibody
BRCA1 Reaktivität: Human WB, IF, IP, FACS, ICC Wirt: Maus Monoclonal RAY unconjugated

anti-Breast Cancer 1 (BRCA1) (AA 1524-1781) antibody
BRCA1 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Breast Cancer 1 (BRCA1) (pSer1524) antibody
BRCA1 Reaktivität: Human ELISA, FACS Wirt: Kaninchen Polyclonal unconjugated

Applikationshinweise

Optimal working dilution should be determined by the investigator.

Beschränkungen

Nur für Forschungszwecke einsetzbar
Format

Liquid

Konzentration

1.0 mg/mL
Milner, Wombwell, Eckersley, Barnes, Warwicker, Van Dorp, Rowlinson, Dearden, Hughes, Harbron, Wellings, Hodgson, Womack, Gray, Lau, OConnor, Marsden, Kvist: "Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours." in: Virchows Archiv : an international journal of pathology, Vol. 462, Issue 3, pp. 269-79, (2013) (PubMed).
Target

BRCA1 (Breast Cancer 1 (BRCA1))

Andere Bezeichnung

BRCA1 (BRCA1 Produkte)

Hintergrund

Synonyms: BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN

Gen-ID

672

UniProt

P38398

Pathways

Zellzyklus, DNA Reparatur, Intracellular Steroid Hormone Receptor Signaling Pathway, Positive Regulation of Response to DNA Damage Stimulus